TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT05785507 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT05061654 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT05048797 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04259788 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05132998 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05132998 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06457646 — Predictive Biomarker (PRD): HTR2A mRNA
Genes: HTR2A; HTR2
Study NCT05811546 — Predictive Biomarker (PRD): DNMT1 mRNA
Genes: DNMT1; AIM; CXXC9; DNMT
Study NCT05424536 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06542939 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05816642 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT06456281 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT04860895 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05201248 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT05854576 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study NCT05854576 — Surrogate Endpoint (SUR): Serum calcium
Study NCT06230185 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT06230185 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT05472389 — Predictive Biomarker (PRD): SCN1A mRNA
Genes: SCN1A; NAC1; SCN1
Study NCT04710641 — Predictive Biomarker (PRD): CEBPA mRNA
Genes: CEBPA; CEBP
Study NCT06647459 — Predictive Biomarker (PRD): TTN mRNA
Genes: TTN
Study NCT05255393 — Predictive Biomarker (PRD): SLN mRNA
Genes: SLN
Study NCT06384131 — Monitoring Biomarker (MOI): HBV DNA
Study NCT05603052 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06327399 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04739800 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06037785 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06762327 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT06762327 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT05289609 — Predictive Biomarker (PRD): DCD mRNA
Genes: DCD; AIDD; DSEP
Study NCT04557228 — Predictive Biomarker (PRD): ADAM17 mRNA
Genes: ADAM17; CSVP; TACE
Study NCT06468709 — Predictive Biomarker (PRD): AIP mRNA
Genes: AIP; XAP2
Study NCT06406673 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT05403242 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05159245 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Mucin-1
Genes: MUC1; PUM
Study NCT04903327 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT05659173 — Predictive Biomarker (PRD): VDR mRNA
Genes: VDR; NR1I1
Study NCT05352828 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT05514158 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05352295 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05352295 — Predictive Biomarker (PRD): TNFRSF11B mRNA
Genes: TNFRSF11B; OCIF; OPG
Study NCT05352295 — Predictive Biomarker (PRD): AGER mRNA
Genes: AGER; RAGE
Study NCT05585970 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT06343064 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06343064 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT04781634 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04781634 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT05728346 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06363565 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT05129878 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06072937 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT05735366 — Predictive Biomarker (PRD): CLDN6 mRNA
Genes: CLDN6; UNQ757/PRO1488
Study NCT05094934 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05710211 — Predictive Biomarker (PRD): ASXL1 mRNA
Genes: ASXL1; KIAA0978
Study NCT05089448 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05067933 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05427396 — Predictive Biomarker (PRD): BTLA mRNA
Genes: BTLA
Study NCT00324831 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT06003556 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06155591 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05277246 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05277246 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT05277246 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05277246 — Monitoring Biomarker (MOI): Matrix metalloproteinase 8
Genes: MMP8; CLG1
Study NCT06067048 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT05569538 — Predictive Biomarker (PRD): KDM1A mRNA
Genes: KDM1A; AOF2; KDM1; KIAA0601; LSD1
Study NCT05764473 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03581240 — Predictive Biomarker (PRD): Zinc finger CCHC domain-containing 1
Genes: LIN28A; CSDD1; LIN28; ZCCHC1
Study NCT03581240 — Predictive Biomarker (PRD): MYCN mRNA
Genes: MYCN; BHLHE37; NMYC
Study NCT06300723 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT06300918 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05382871 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06304597 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT06304597 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT05625035 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05270902 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05812014 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04914754 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02801318 — Predictive Biomarker (PRD): REM1 mRNA
Genes: REM1; GES; REM
Study NCT05113186 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT05351346 — Predictive Biomarker (PRD): DDIT3 mRNA
Genes: DDIT3; CHOP; CHOP10; GADD153
Study NCT06450548 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05687279 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04909892 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT05720156 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT05720156 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT05215743 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study NCT05533463 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT05825924 — Surrogate Endpoint (SUR): Exhaled carbon monoxide
Study NCT05698264 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05698264 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05678062 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT05290987 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study NCT05181774 — Predictive Biomarker (PRD): KLHL17 mRNA
Genes: KLHL17; AF
Study NCT05181774 — Predictive Biomarker (PRD): DIAPH2 mRNA
Genes: DIAPH2; DIA
Study NCT06096974 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT06096974 — Predictive Biomarker (PRD): HRAS mRNA
Genes: HRAS; HRAS1
Study NCT06096974 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study NCT06337474 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04881929 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05179603 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT06533644 — Predictive Biomarker (PRD): SYNC mRNA
Genes: SYNC; SYNC1
Study NCT06605417 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT06604975 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study NCT06608706 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study NCT05472558 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT03591614 — Predictive Biomarker (PRD): DKK1 mRNA
Genes: DKK1; UNQ492/PRO1008
Study NCT05826964 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05826964 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT05826964 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05826964 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05826964 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT05001243 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05310110 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05394675 — Predictive Biomarker (PRD): CLDN6 mRNA
Genes: CLDN6; UNQ757/PRO1488
Study NCT04865237 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05295823 — Predictive Biomarker (PRD): PVR mRNA
Genes: PVR; PVS
Study NCT04694807 — Predictive Biomarker (PRD): PGD mRNA
Genes: PGD; PGDH
Study NCT04732637 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02823132 — Predictive Biomarker (PRD): MBL2 mRNA
Genes: MBL2; COLEC1; MBL
Study NCT05445908 — Predictive Biomarker (PRD): KL mRNA
Genes: KL
Study NCT05445908 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05445908 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06375642 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT06375642 — Predictive Biomarker (PRD): FGFR1 mRNA
Genes: FGFR1; BFGFR; CEK; FGFBR; FLG; FLT2; HBGFR
Study NCT06375642 — Predictive Biomarker (PRD): CSF1R mRNA
Genes: CSF1R; FMS
Study NCT06088966 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05607498 — Predictive Biomarker (PRD): RORA
Genes: RZRA; ROR1; ROR2; ROR3; NR1F1; ROR-alpha; RORalpha; RORa1
Study NCT05022758 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT06249282 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT06115928 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05298995 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study NCT05298995 — Predictive Biomarker (PRD): CASP9
Genes: MCH6; ICE-LAP6; APAF-3; PPP1R56
Study NCT05886569 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05886569 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05595629 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05013983 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT03958760 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT03958760 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT04526145 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05227950 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT04797260 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT05727709 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT04656210 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT04138875 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT05336058 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT05817929 — Monitoring Biomarker (MOI): Angiopoietin-1
Genes: ANGPT1; KIAA0003
Study NCT05817929 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Angiopoietin-2
Genes: ANGPT2
Study NCT00344734 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04813796 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06104501 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06209736 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study NCT05553964 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05976503 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05666895 — Safety Biomarker (SAF): Platelet to lymphocyte
Study NCT05321862 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study NCT06185842 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT05662904 — Predictive Biomarker (PRD): Myeloid cell surface antigen CD33
Genes: CD33; SIGLEC3
Study NCT05662904 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT01997268 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT01997268 — Predictive Biomarker (PRD): PLA2G1B mRNA
Genes: PLA2G1B; PLA2; PLA2A; PPLA2
Study NCT01997268 — Surrogate Endpoint (SUR): Serum triglycerides
Study NCT04690192 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04105439 — Monitoring Biomarker (MOI): Urokinase plasminogen activator surface receptor
Genes: PLAUR; MO3; UPAR
Study NCT06356779 — Predictive Biomarker (PRD): OMD mRNA
Genes: OMD; SLRR2C; UNQ190/PRO216
Study NCT04900610 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04831528 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT04801888 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05067920 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05744375 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05278702 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05425290 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05425290 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00072891 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06301191 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT06582186 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT06582186 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05397587 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05052424 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05558228 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06189456 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT04916327 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT05250050 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study NCT05518773 — Pharmacodynamic Biomarker (PDY): Survival motor neuron protein
Genes: SMN1; SMN; SMNT;; SMN2; SMNC
Study NCT06014073 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06014073 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study NCT05360563 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT04969965 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04969965 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04913597 — Predictive Biomarker (PRD): TPO mRNA
Genes: TPO
Study NCT06103006 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT06196424 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06196424 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT06196424 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT06196424 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT06196424 — Predictive Biomarker (PRD): ROS1
Genes: MCF3; ROS; c-ros-1
Study NCT06196424 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study NCT06196424 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT06196424 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06196424 — Predictive Biomarker (PRD): NTRK
Study NCT06196424 — Pharmacodynamic Biomarker (PDY): Tropomyosin-related kinase A
Genes: NTRK1; MTC; TRK; TRKA
Study NCT04815122 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study NCT04815122 — Safety Biomarker (SAF): SLC6A3
Genes: DAT
Study NCT06607081 — Predictive Biomarker (PRD): ERAS mRNA
Genes: ERAS; HRAS2; HRASP
Study NCT06127966 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study NCT05273268 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05824806 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06362148 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05517213 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT05703620 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06306690 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study NCT04935476 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06420154 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04466475 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT04808050 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00051467 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04992221 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06459037 — Predictive Biomarker (PRD): NRP1 mRNA
Genes: NRP1; NRP; VEGF165R
Study NCT06459037 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05225896 — Predictive Biomarker (PRD): DNER mRNA
Genes: DNER; BET; UNQ262/PRO299
Study NCT04886011 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT05748704 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00481559 — Surrogate Endpoint (SUR): Plasma methotrexate
Study NCT06306456 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05008991 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT05199376 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT06447090 — Predictive Biomarker (PRD): VMAC mRNA
Genes: VMAC
Study NCT05832112 — Safety Biomarker (SAF): Ornithine transcarbamylase
Genes: OTC
Study NCT03594162 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT03594162 — Predictive Biomarker (PRD): CASP9
Genes: MCH6; ICE-LAP6; APAF-3; PPP1R56
Study NCT05928507 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04864132 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT05281614 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05680922 — Predictive Biomarker (PRD): DLL3 mRNA
Genes: DLL3
Study NCT04887662 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05779813 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT05779813 — Predictive Biomarker (PRD): GRN mRNA
Genes: GRN
Study NCT04883528 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT06299722 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06299722 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05742880 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05143970 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06221696 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06310512 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05157152 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT05066945 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT06146036 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05565911 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study NCT06216392 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05692661 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05857124 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT06386341 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04726579 — Predictive Biomarker (PRD): MBP mRNA
Genes: MBP
Study NCT05374577 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT05945771 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05962034 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05479435 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05479435 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT05349292 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT04999111 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06492811 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05476432 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study NCT05650138 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05242354 — Predictive Biomarker (PRD): CD80 mRNA
Genes: CD80; CD28LG; CD28LG1; LAB7
Study NCT05242354 — Safety Biomarker (SAF): Hemoglobin scavenger receptor
Genes: CD163; M130
Study NCT06305533 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT05703893 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04210154 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04557475 — Predictive Biomarker (PRD): FGR mRNA
Genes: FGR; SRC2
Study NCT04718012 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT05243212 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA